MTHFR c.1793G>A polymorphism is associated with congenital cardiac disease in a Chinese population

Cardiology in the Young

Volumn 20, Issue 3, 2010, Pages 318-326

  Xu, Jing ^a   Xu, Xiaohan ^a   Xue, Lei ^a   Liu, Xiang ^a   Gu, Haiyong ^c   Cao, Hailong ^a   Qiu, Wanshan ^d   Hu, Zhibin ^b   Shen, Hongbing ^b   Chen, Yijiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetics; Homocysteine; Malformation; Variant

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE DEHYDROGENASE; DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; CHINESE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART VENTRICLE SEPTUM DEFECT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHILD; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART DEFECTS, CONGENITAL; INCIDENCE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK FACTOR;

CHILD; CHINA; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953617511     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110000247     Document Type: Article

References (28)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900.
2. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006; 28: 680-689.
3. Botto LD, Mulinare J. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000; 151: 878-884.
4. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 2995-3014.
5. Boot MJ, Steegers-Theunissen RP, Poelmann RE, van Iperen L, Gittenberger-de Groot AC. Cardiac outflow tract malformations in chick embryos exposed to homocysteine. Cardiovasc Res 2004; 64: 365-373.
6. Li D, Pickell L, Liu Y, Wu Q, Cohn JS, Rozen R. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am J Clin Nutr 2005; 82: 188-195.
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
8. Hol FA, van der Put NM, Geurds MP, et al. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate- dehydrogenase, methenyltetrahydrofolatecyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet 1998; 53: 119-125.
9. Christensen KE, Patel H, Kuzmanov U, Mejia NR, Mackenzie RE. Disruption of the mthfd1 gene reveals a monofunctional 10-formyltetrahydrofolate synthetase in mammalian mitochondria. J Biol Chem 2005; 280: 7597-7602.
10. Parle-McDermott A, Kirke PN, Mills JL, et al. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 2006; 14: 768-772.
11. Shi M, Caprau D, Romitti P, Christensen K, Murray JC. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1 and GCP2. Birth Defects Res A Clin Mol Teratol 2003; 67: 545-549.
12. Vizcaino G, Diez-Ewald M, Herrmann FH, Schuster G, Torres- Guerra E, Arteaga-Vizcaino M. Homocysteinemia and its relationship with the methylentetrahydrofolate reductase polymorphism in various ethnic groups from western Venezuela. Invest Clin 2005; 46: 347-355.
13. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A-.C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415.
14. Rady PL, Szucs S, Grady J, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, 1793G.A. Am J Med Genet 2002; 107: 162-168.
15. van Beynum IM, den Heijer M, Blom HJ, Kapusta L. The MTHFR 677C-.T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 2007; 100: 743-753.
16. Hobbs CA, Cleves MA, Melnyk S, Zhao W, James SJ. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 2005; 81: 147-153.
17. Storti S, Vittorini S, Lascone MR, et al. Association between 5,10- methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med 2003; 41: 276-280.
18. McBride KL, Fernbach S, Menesses A, et al. A family-based association study of congenital left-sided heart malformations and 5, 10- methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 2004; 70: 825-830.
19. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine study. Am J Med 2004; 117: 26-31.
20. van Driel LM, Verkleij-Hagoort AC, de Jonge R, et al. Two MTHFR polymorphisms, maternal B-vitamin intake, and CHDs. Birth Defects Res A Clin Mol Teratol 2008; 82: 474-481.
21. Brody LC, Conley M, Cox C, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002; 71: 1207-1215.
22. Cheng J, Zhu WL, Dao JJ, Li SQ, Li Y. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Environ Sci 2005; 18: 58-64.
23. Wang L, Ke Q, Chen W, et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res 2007; 13: 2526-2532.
24. Shen H, Newmann AS, Hu Z, et al. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep 2005; 13: 355-360.
25. Shaw GM, Iovannisci DM, Yang W, et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Genet A 2005; 138: 21-26.
26. van B, Kapusta L, Den H, et al. Maternal MTHFR 677C.T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006; 27: 981-987.
27. Pereira AC, Xavier-Neto J, Mesquita SM, Mota GFA, Lopes AA, Krieger JE. Lack of evidence of association between MTHFR 677C.T polymorphism and congenital heart disease in a TDT study design. Int J Cardiol 2005; 105: 15-18.
28. Verkleij-Haqoort A, Bliek J, Sayed-Tabatabaei F, Ursem N, Steeqers E, Steegers-Theunissen R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am Med Genet A 2007; 143: 952-960.